The Canadian pain management drugs market is expected to grow at a CAGR of 3.19% from 2025 to 2030.
The rising prevalence of chronic diseases is one of the major drivers of the pain management drugs market in the country. In this regard, obesity is regarded as one of the significant factors that is fueling the growth of the market in Canada.
A World Obesity Federation report forecasts that over 10 million Canadians will be overweight or obese by 2025. The report approximates that the cost of caring for obesity-related disease across the world will amount to $1.5 trillion each year starting in 2025, when 2.7 billion people (one-third of the population of the planet) will be overweight or obese individuals. In Canada, 34% of individuals above 18 years of age will be living with obesity in eight years. Obesity worsens joint strain, with every additional pound producing 4–6 pounds of pressure on knees and resulting in a higher prevalence of arthritis in obese persons vs in individuals with average BMI.
The rise in the prevalence of skin care conditions, especially chronic afflictions like psoriasis and eczema, is another primary growth driver of Canada's pain management market. Around 1 million people have psoriasis , and 17% have eczema, both frequently associated with neuropathic or inflammatory pain. The conditions, fueled by environmental and stress factors, drive the need for pain relief products, such as topical analgesics and non-opioid drugs. The sophisticated treatments, like biologics and phototherapy, though dealing with skin manifestations, occasionally demand concomitant pain control, driving the market higher.
Furthermore, cosmetic treatments such as laser and chemical peel, which have become increasingly popular, may induce post-procedure pain, also fueling the need for pain management devices and drugs.
The ageing population, which is more susceptible to skin pain, and increased awareness of non-opioid alternatives during the opioid crisis, further drive market growth. Restraint in access to dermatological specialist care in rural regions demands greater dependence on pain management solutions, thereby supporting the market's strong growth path.
Canada Pain Management Drug Market Segmentation